FDA Clearance Tracker · P130022-S035
Nevro Corp Senza Spinal Cord Stimulation (SCS) System
Last checked: Nov 20, 2026Latest source record: Feb 26, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Feb 26, 2021
Approved
Time to decision
198 days
Received Aug 12, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P130022-S035
- Device name
- Nevro Corp Senza Spinal Cord Stimulation (SCS) System
- Applicant
- Nevro Corporation
- Applicant location
- Redwood City, CA
- Received
- Aug 12, 2020
- Decided
- Feb 26, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P130022
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a new Nordson Medicals manufacturing site of the Implantable Pulse Generators (IPGs) of the Senza neuromodulation system located at 105 E Tasman Dr. San Jose, CA, 95134. Pro-Tech will continue to perform final packaging and sterilization.
Source documents
Other decisions for Nevro Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Senza Spinal Cord Stimulation (SCS) SystemPMA supplement
P130022-S042 · Decided Jan 18, 2022 · 180 days after receipt · Panel Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.